Download image:
919-541-7276

Jenny L. Wiley

Senior Fellow, Behavioral Pharmacology

Jenny Wiley, PhD, is a leading expert in behavioral pharmacology who has worked extensively with various multidisciplinary and multi-institutional teams focused on studies that use a wide range of methods from molecular to behavioral.

Dr. Wiley designs and supervises a program of in vivo research that complements existing strengths of the Center for Discovery and Analytical Sciences, including the synthesis and development of candidate medications and investigation of neural mechanisms underlying substance abuse. She also conducts independent National Institutes of Health grant-supported research in the area of cannabinoid pharmacology, an area in which she has an extensive record of peer-reviewed publications.

Before joining RTI in March 2010, Dr. Wiley was a professor in the Department of Pharmacology and Toxicology at VCU, where she still maintains an affiliate appointment. Additionally, she has been involved in governance of the International Cannabinoid Research Society for many years and served as the Society’s president at the 2013 meeting.

Education

  • Postdoctoral Fellowship, Pharmacology, Virginia Commonwealth University
  • PhD, Biological Psychology, Virginia Commonwealth University
  • MS, Biological Psychology, Virginia Commonwealth University
  • BS, Psychology (minor: English), College of William and Mary

Latest Publications

Wiley, J.L., Marusich, J.A., Lefever, T.W., Antonazzo, K.R., Wallgren, M.T., Cortes, R.A., Patel, P.R., Grabenauer, M., Moore, K.N., & Thomas, B.F. (2015). AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and potency of novel synthetic cannabinoids in producing delta9-tetrahydrocannabinol-like effects in mice. Journal of Pharmacology and Experimental Therapeutics, Advance Online Publication .
Ignatowska-Jankowska, B.M., Baillie, G.L., Kinsey, S., Crowe, M., Ghosh, S., Owens, R.A., Damaj, M.I., Poklis, J., Wiley, J.L., et al. (2015). A cannabinoid CB receptor positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects. Neuropsychopharmacology, Advance Online Publication .
Wakley, A.A., Wiley, J.L., & Craft, R.M. (2015). Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats. Pharmacology, Biochemistry, and Behavior, 133 :111-121.
Walentiny, D.M., Vann, R.E., & Wiley, J.L. (2015). Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice. Neuropharmacology, 93 :237-242.
Ignatowska-Jankowska, B.M., Wilkerson, J.L., Mustafa, M., Abdullah, R., Niphakis, M., Wiley, J.L., et al. (2015). Selective monoacylglycerol lipase inhibitors: Antinociceptive vs. cannabimimetic effects in mice. Journal of Pharmacology and Experimental Therapeutics, 353 (2):424-432.
View all publications by Jenny L. Wiley (170)

Expertise

  • Cannabinoid Pharmacology
  • Behavioral Pharmacology
  • Neuropharmacology
  • Animal Models of Substance Abuse

News